TherapeuticsMD, Inc. — Director's Dealing 2013

May 3, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2013-05-01

Reporting Person: SEGAL NICHOLAS (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-05-01	Non-Qualified Stock Option	$2.64	A	50000	Acquired	2023-05-01	Common Stock (50000)	Indirect

Footnotes

F1: Of the derivative securities, Segal ownS 192,057 shares directly and 61,372 shares through 4th Generation Private Equity.